Recent Updates
Recently added Catalysts

Karyopharm Therapeutics Inc.

KPTIQFDA catalysts, PDUFA dates & pipeline intelligence
$0.03
▼ 0 · -0.39%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full KPTIQ financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
Volume
1.58 M
Value Traded
38.63 K
Short % Float
-
+45.14%Week

Cash Data

Unlock KPTIQ cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
576.11 K
EPS (TTM)
-9.91
P/E Ratio
-
Ent. Value
-64.53 M
Total Shares
22.68 M
Float Shares
-
Insiders
-
Institutions
-

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Phase 2 data presentation
selinexor (SENTRY-2)
JAKi-naïve myelofibrosis
Fast TrackOrphan
Phase 2Small MoleculesOncology
Unlock every KPTIQ catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

KPTIQ Catalyst Timeline

Dated clinical, regulatory and corporate events for Karyopharm Therapeutics Inc.

Catalyst Timeline

Dated clinical, regulatory & corporate events for Karyopharm Therapeutics Inc.

3Total events
3Upcoming
1Tier-1 (high impact)
2026 to 2027Coverage

Upcoming catalysts 2

T3Poster Presentation
Subscribe to view catalyst details
Selinexor
T2Oral Presentation
Subscribe to view catalyst details
Selinexor
Unlock the full KPTIQ catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How KPTIQ actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all KPTIQ historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Pipeline Score
Pipeline Value
Valuation Signal
2
Drugs Scored
rNPV / MCap
Top Drug
Top 20%
Micro Cap
(rank 146 of 724)
Percentile Rank
Showing 8 of 28 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
Selinexor Small MoleculesNCT04717700Multiple MyelomaPhase 3 ACTIVE NOT_RECRUITING 1,143Jun 1, 2029
Selinexor Small MoleculesNCT04442022Relapsed/Refractory Diffuse Large B-cell LymphomaPhase 2/3 ACTIVE NOT_RECRUITING 501Dec 1, 2026
Selinexor Small MoleculesNCT05611931Endometrial CancerPhase 3 ACTIVE NOT_RECRUITING 520Jan 1, 2028
Selinexor Small MoleculesNCT04562870MyelofibrosisPhase 3 ACTIVE NOT_RECRUITING 549Sep 1, 2026
Selinexor Small MoleculesNCT04414475Multiple Myeloma, RefractoryPhase 2 RECRUITING 127Jan 1, 2028
Selinexor Small MoleculesNCT02227251Diffuse Large B-cell LymphomaPhase 2 ACTIVE NOT_RECRUITING 244Dec 1, 2026
Selinexor Small MoleculesCompletedNCT04256707Non-Small Cell Lung Carcinoma (NSCLC)Phase 1/2 COMPLETED 80Jul 31, 2024
KPT-8602 Small MoleculesCompletedNCT02649790Relapsed/Refractory Multiple Myeloma (RRMM)Phase 1/2 COMPLETED 277Dec 23, 2024
Unlock the KPTIQ pipeline intelligence model
PTRS, rNPV, enrollment velocity, trial design quality and ML risk signals for every asset above.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every KPTIQ program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every KPTIQ trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock KPTIQ insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
No insider trades match the selected filters.
Unlock the full KPTIQ insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in KPTIQ

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in KPTIQ for Q2 2026.
Unlock every fund holding KPTIQ
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in KPTIQ
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see KPTIQ ownership
Insider and institutional ownership, quarter by quarter.

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock KPTIQ option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live KPTIQ option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock KPTIQ options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How KPTIQ ranks across every disease it competes in

Competitive Position is a premium feature
See how KPTIQ ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

KPTIQ News

About Karyopharm Therapeutics Inc.

BIOPHARMAWATCH ELITE
Trade the next KPTIQ catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime